Suzhou’s Innovent Strikes $457 Million Deal with CAS for Immuno-Oncology Candidate Sep 8, 2017 Life Science
China’s yuan has fully recovered from 2016 and analysts say there’s still room to run Sep 7, 2017 Others
Yisheng Biopharma Reports “Breakthrough” Efficacy of Lead Immuno-Oncology Drug Sep 1, 2017 Life Science